On Nov 04, 2025, CDNA reported earnings of 0.28 USD per share (EPS) for Q3 25, beating the estimate of 0.14 USD, resulting in a 93.77% surprise. Revenue reached 100.06 million, compared to an expected 97.16 million, with a 2.98% difference. The market reacted with a +13.84% price change (close before vs. close after earnings).
Looking ahead to Q4 25, 11 analysts forecast an EPS of 0.24 USD, with revenue projected to reach 105.31 million USD, implying an decrease of -14.29% EPS, and increase of 5.25% in Revenue from the last quarter.
Industry Peers’ Earnings
Industry Peers' Earnings displays EPS earnings data from companies in the same industry. Click on a card to view more details.
Danaher Corporation
Report Date
Jan 28, 2026 For Q4 25
Estimate
$2.17
Actual
$2.23
Surprise
+2.56%
HCA Healthcare, Inc.
Report Date
Jan 27, 2026 For Q4 25
Estimate
$7.53
Actual
$8.14
Surprise
+8.05%
Elevance Health, Inc.
Report Date
Jan 28, 2026 For Q4 25
Estimate
$3.12
Actual
$3.33
Surprise
+6.46%
FAQ
What were CareDx, Inc.'s earnings and revenue for the latest quarter Q3 2025?
For Q3 2025, CareDx, Inc. reported EPS of $0.28, beating estimates by 93.77%, and revenue of $100.06M, 2.98% above expectations.
How did the market react to CareDx, Inc.'s Q3 2025 earnings?
The stock price moved up 13.84%, changed from $14.52 before the earnings release to $16.53 the day after.
When is CareDx, Inc. expected to report next?
The next earning report is scheduled for Feb 24, 2026.
What are the forecasts for CareDx, Inc.'s next earnings report?
Based on 11
analysts, CareDx, Inc. is expected to report EPS of $0.24 and revenue of $105.31M for Q4 2025.